ZYME

Zymeworks Inc. is a Vancouver-based clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative biotherapeutics targeting cancer. Leveraging its proprietary platforms, the company has established a diverse pipeline that includes antibody-drug conjugates and bispecific therapeutics, aimed at addressing significant unmet medical needs in oncology. With a strong focus on advancing targeted therapies and strategic collaborations, Zymeworks is well-positioned to emerge as a pivotal player in the biopharmaceutical landscape, driving the delivery of transformative treatments to patients.